On 1/21/25, Corcept Therapeutics Inc (NASDAQ: CORT) stock enjoyed a major increase of 10.5%, closing at $61.11. Moreover, above average trading volume at 136% of normal accompanied the advance. Relative to the market the stock has been exceptionally strong over the last nine months and has risen 22.6% during the last week.
Current PriceTarget Research Rating
Corcept Therapeutics has a current Value Trend Rating of C (Neutral). The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Corcept Therapeutics has a poor Appreciation Score of 20 but a very high Power Rating of 94, leading to the Neutral Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment